Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera
These results demonstrate the utility of proteomics to evaluate correlates or predictors of serological responses to SARS-CoV-2 vaccination.
Authors
- Uma Mudunuri
- Brian A. Sellers (ORCID: https://orcid.org/0000-0003-1268-0341)
- Keyur Talsania
- Nancy Roche
- Lígia A. Pinto (ORCID: https://orcid.org/0000-0002-3130-9882)
- Troy J. Kemp (ORCID: https://orcid.org/0000-0002-1197-7525)
- Heidi Hempel (ORCID: https://orcid.org/0000-0003-2830-0593)
- James M. Cherry
- Thomas E. Hickey
Institutions
- National Institutes of Health (US)
- Frederick National Laboratory for Cancer Research (US)
- National Institute of Allergy and Infectious Diseases (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.3389/fimmu.2024.1502458
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute